Tirzepatide - 5mg x 10 vial kit

$155.00 USD

10 vials of 5mg each.

Important: For laboratory and research use only. Not for human consumption.

Under no circumstances should any products be used without the express direction of a licensed physician.

Description

A kit of 10 vials of Tirzepatide. Each vial contains 5mg of lyophilized Tirzepatide.

Tirzepatide is a once-weekly injectable medication that activates both GIP and GLP-1 receptors. Those pathways affect appetite, satiety, insulin secretion, and blood-glucose regulation.

It has unusually strong clinical evidence for both type 2 diabetes and obesity. In major randomized trials, tirzepatide produced large reductions in HbA1c and substantially greater weight loss than placebo. In SURMOUNT-1, average weight loss reached roughly 15% to 21% over 72 weeks, depending on dose. Longer-term follow-up showed that substantial weight loss was largely maintained through 176 weeks while treatment continued.

It also performs well against established GLP-1 therapy. In SURPASS-2, tirzepatide lowered both HbA1c and body weight more than semaglutide 1 mg in people with type 2 diabetes.

 

 

Tirzepatide is the active ingredient in Mounjaro® and Zepbound®. These names are registered trademarks of their respective owners. This product is not affiliated with, endorsed by, or equivalent to any branded product.

A reconstitution with 1mL of Bacteriostatic Water gives a dose of 1mg / 0.2mL of diluent.